Ian B. Walters - 27 Apr 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Role: Director
Signature: /s/ Ian B. Walters
Issuer symbol: ENZB
Transactions as of: 27 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 29 Apr 2022, 16:35:44 UTC
Next filing: 14 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENZ	Common Stock, $0.01 Par Value	Award	$0	+39,063		$0.000000	39,063	27 Apr 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ENZ	Stock Option (to acquire Common Stock)						77,101	27 Apr 2022	Common Stock	77,101	$2.63	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted Restricted Stock Units that will vest, subject to the individual continuing to serve as a member of the board of directors of Enzo Biochem, Inc., in two equal annual instalments, beginning on April 27, 2023.
F2	The stock options have a five-year term. Fifty percent of the stock options have vested, and the remaining fifty percent will vest on January 11, 2023.